Publicaciones en colaboración con investigadores/as de Hospital Angeles Pedregal (1)

2022

  1. Bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemia: final results from the BFORE trial

    Leukemia, Vol. 36, Núm. 7, pp. 1825-1833